Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-beta-lactamase encoded by a conjugative plasmid

Antimicrob Agents Chemother. 2004 Feb;48(2):648-50. doi: 10.1128/AAC.48.2.648-650.2004.

Abstract

Resistance to carbapenems is an emerging problem among gram-negative hospital pathogens. A transferable plasmid encoding the VIM-4 metallo-beta-lactamase was detected in isolates of Klebsiella pneumoniae and Enterobacter cloacae obtained from a single patient under carbapenem therapy. Thus, enterobacteria appear to increasingly contribute to the spread of VIM-type enzymes.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Conjugation, Genetic / genetics*
  • Enterobacter cloacae / drug effects
  • Enterobacter cloacae / enzymology*
  • Enterobacter cloacae / genetics*
  • Enterobacteriaceae Infections / microbiology
  • Female
  • Humans
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / enzymology*
  • Klebsiella pneumoniae / genetics*
  • Plasmids / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • beta-Lactamases / biosynthesis*
  • beta-Lactamases / genetics*

Substances

  • beta-Lactamases
  • metallo-beta-lactamase VIM-4, Enterobacter cloacae
  • metallo-beta-lactamase VIM-4, Klebsiella pneumoniae